Ping An Biomedical
PASW
3 hedge funds and large institutions have $25.4K invested in Ping An Biomedical in 2025 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, reducing their positions, and 1 closing their positions.
0.14% more ownership
Funds ownership: 0.11% → 0.25% (+0.14%)
0% more funds holding
Funds holding: 3 → 3 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
9% less capital invested
Capital invested by funds: $27.8K → $25.4K (-$2.37K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$15.4K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$3.1K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$396 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
-$52 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
XT
1
XTX Topco
George Town,
Cayman Islands
| $11.6K | +$15.4K | +23,079 | New |
|
|
2
Citadel Advisors
Miami,
Florida
| $11.5K | +$396 | +593 | +3% |
|
|
3
UBS Group
Zurich,
Switzerland
| $2.37K | +$3.1K | +4,651 | +6,371% |
|
|
4
JP Morgan Chase
New York
| – | -$52 | -42 | Closed |
|
PASW Hedge Fund Activity: Q4 2025 in Review
3 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in Ping An Biomedical (PASW) for Q4 2025, worth a combined $25.4K — down 8.5% from $27.8K a quarter earlier.
Fund positioning in PASW was balanced in Q4 2025: 1 fund opened new positions, 1 closed out, 2 added to existing stakes and 0 trimmed.
The largest buyer was XTX Topco, opening a new position worth an estimated $15.4K. The largest seller was JP Morgan Chase, exiting entirely with an estimated $52 sold.
- 3 institutional investors held Ping An Biomedical (PASW) as of Q4 2025, unchanged from Q3 2025.
- Funds reported $25.4K of Ping An Biomedical stock for Q4 2025, down 8.5% quarter-over-quarter.
- 1 fund opened new Ping An Biomedical positions in Q4 2025 and 1 closed out, a net change of 0 holders.
- The largest Ping An Biomedical buyer in Q4 2025 was XTX Topco, an estimated $15.4K added.
- The largest Ping An Biomedical seller in Q4 2025 was JP Morgan Chase, an estimated $52 sold.
Based on aggregated 13F filings for Q4 2025.